POVIDONE IODINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Povidone Iodine, and what generic alternatives are available?
Povidone Iodine is a drug marketed by Allegiance Hlthcare and is included in one NDA.
The generic ingredient in POVIDONE IODINE is povidone-iodine. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the povidone-iodine profile page.
Summary for POVIDONE IODINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 185 |
Patent Applications: | 3,954 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for POVIDONE IODINE |
DailyMed Link: | POVIDONE IODINE at DailyMed |
Recent Clinical Trials for POVIDONE IODINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Menoufia University | Phase 2/Phase 3 |
Sunnybrook Health Sciences Centre | Phase 4 |
Randy Loftus | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for POVIDONE IODINE
US Patents and Regulatory Information for POVIDONE IODINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allegiance Hlthcare | POVIDONE IODINE | povidone-iodine | SOLUTION;TOPICAL | 019522-001 | Mar 31, 1989 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |